Briacell Therapeutics Corp BCTX

$3.06 -0.10 (-3.16%)

Valuation

Market cap
27,594,000
Revenue TTM
$0
Net income TTM
$-34,900,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
109,700
Avg volume
95,210
Day's range
$3.01 – $3.20
Shares out
8,732,000
Stochastic %K
6%
Beta
1.26
Analysts
—
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604-921-1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

No headlines yet.

Stocktwits

letsdodiz Nov 21, 6:25 PM
$BCTX CAPR money was gonna come into SLS and SLS money was going to flow into other P3 candidates. I guess that chain of money flow is broken and gone now - all in a week.
0 replies
tbagoni Nov 20, 4:15 PM
$BCTX Boy, right about now would be a good time for positive phase 3 results! This market is deleting a lot of cash!
3 replies
BCTX20bMC Nov 19, 11:28 PM
$BCTX a stranger’s comment on the internet is insulting to you? You are searching for attention…making moron 10-15% chances comments. There is a ton of info a 5 yr old can find here in 15 mins…or watch any of the numerous recent presentations. Bc you trolled…makes you a moron.
0 replies
AliceFireSteam Nov 19, 10:48 PM
$BCTX a reminder table for all
2 replies
PensiveInvestor Nov 19, 9:13 PM
$BCTX They doubled the survival to 16.6 months on patients who normally have survival between 6.7 to 9.8 months. The fact that the phase 2 consist of 54 patients, it is not impossible to assume that they can do it in the phase 3 with 177 patients. Also they don't need to double , they need to improve to 40% in interim analysis or 30% in final analysis. There is a chance, and the longer it takes , the better the odds, similar to $SLS.
1 replies
Kris600 Nov 19, 8:56 PM
$BCTX question to holders: why do you believe this company can succeed? Based on not impressive phase 2 results and statistics there is just 10-15% chance of success. I'm asking about facts, not wishful thinking. Thanks in advance.
3 replies
AliceFireSteam Nov 19, 8:30 PM
$BCTX if HR is between 0.6 and 0.7 at interim 1 the company is most likely to dilute to hell and back, as they would need 30M (at least) for another year of operations.
1 replies
PensiveInvestor Nov 19, 8:24 PM
$BCTX what will happen if hr is between 0.6 and 0.7 let's say 0.65? Will it tank or will it rise or will it stay the same?
0 replies